The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.
The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'
Our two week online Winter School (13th to 24th of February 2023) prepares professionals and students to meet the complex policy challenges that face Europe and the World in the field of drugs.
Objective: to explore wastewater analysis as a methodology contributing to EU preparedness and response
Background: COVID-19 has raised the attention of Europe, and globally, on the importance of readiness towards potential emergencies. Improved and innovative monitoring methodologies are at the core of the research-based actions taken to respond to potential threats.
